Wen Shen Selected Research

Wen Shen Research Topics

Disease

28	Neoplasms (Cancer) 10/2023 - 12/2008
19	Pain (Aches) 09/2023 - 12/2004
9	Hypersensitivity (Allergy) 09/2023 - 02/2015
7	Hyperalgesia 01/2022 - 10/2010
6	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 12/2007
6	Fibrosis (Cirrhosis) 01/2022 - 06/2019
6	Bone Neoplasms (Bone Cancer) 01/2022 - 10/2010
5	Hypoxia (Hypoxemia) 02/2024 - 01/2013
5	Neuralgia (Stump Neuralgia) 09/2023 - 01/2016
5	Hypertension (High Blood Pressure) 01/2023 - 01/2010
5	Kidney Diseases (Kidney Disease) 01/2023 - 01/2018
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2017
4	Wounds and Injuries (Trauma) 12/2023 - 10/2020
4	Atrophy 11/2023 - 11/2014
4	Atrial Fibrillation 10/2023 - 01/2020
4	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2010
4	Myocardial Infarction 01/2023 - 09/2011
4	Breast Neoplasms (Breast Cancer) 12/2022 - 01/2018
4	Cognitive Dysfunction 06/2022 - 03/2016
4	Hepatic Encephalopathy 12/2021 - 12/2017
4	Ganglion Cysts (Ganglion) 01/2015 - 03/2002
3	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 01/2020
3	Ischemia 07/2023 - 12/2009
3	Liver Neoplasms (Liver Cancer) 01/2023 - 03/2019
3	Reperfusion Injury 01/2023 - 12/2017
3	Hyperkalemia 01/2023 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 11/2013
3	Inflammation (Inflammations) 01/2022 - 01/2016
3	Heart Failure 01/2022 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2011
3	Hemorrhage 01/2021 - 01/2020
3	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 10/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2019 - 01/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2024 - 11/2013
2	Membranous Glomerulonephritis (Membranous Nephropathy) 11/2023 - 01/2022
2	Stroke (Strokes) 07/2023 - 01/2020
2	Thrombosis (Thrombus) 01/2023 - 03/2019
2	Anemia 01/2023 - 08/2021
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 09/2003
2	Iron Overload 01/2023 - 01/2019
2	Hyperthermia 12/2022 - 01/2019
2	Carcinoma (Carcinomatosis) 11/2022 - 07/2022
2	Necrosis 01/2022 - 01/2018
2	Venous Thromboembolism 01/2022 - 01/2020
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 12/2004
2	Hypotension (Low Blood Pressure) 01/2022 - 12/2020

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2011
6	GadoliniumIBA 04/2024 - 11/2014
5	IronIBA 11/2023 - 08/2015
5	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2016
4	CreatinineIBA 02/2024 - 09/2003
4	CytokinesIBA 01/2023 - 02/2015
4	CalciumIBA 01/2023 - 03/2002
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2003
4	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2016
4	plerixafor FDA Link 01/2020 - 04/2014
3	Taurine FDA Link 04/2024 - 01/2012
3	Carbon Tetrachloride (Tetrachloromethane)IBA 02/2024 - 01/2020
3	gadolinium ethoxybenzyl DTPA FDA Link 12/2023 - 01/2018
3	AlbuminsIBA 10/2023 - 01/2023
3	BilirubinIBA 10/2023 - 01/2022
3	Polysaccharides (Glycans)IBA 12/2022 - 12/2019
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
3	Neutralizing AntibodiesIBA 04/2021 - 10/2010
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2018
3	6- (N- (4- aminobutyl)- N- ethyl)amino- 2,3- dihydrophthalazine- 1,4- dione (ABEI)IBA 01/2020 - 09/2011
3	ChemokinesIBA 01/2020 - 04/2014
3	Chemokine ReceptorsIBA 01/2020 - 01/2017
3	Hormones (Hormone)IBA 03/2016 - 11/2013
2	Eosine Yellowish-(YS) (Eosin)IBA 02/2024 - 01/2022
2	Hematoxylin (Haematoxylon)IBA 02/2024 - 01/2022
2	Biocompatible Materials (Biomaterials)IBA 12/2023 - 05/2023
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2023 - 01/2022
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2023 - 01/2023
2	lipoarabinomannan (LAM)IBA 09/2023 - 07/2018
2	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 11/2018
2	Glutamic Acid (Glutamate)FDA Link 07/2023 - 01/2007
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2023 - 01/2023
2	Retinaldehyde (Retinal)IBA 01/2023 - 01/2013
2	Alkaline PhosphataseIBA 10/2022 - 06/2022
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 10/2022 - 06/2022
2	Freund's AdjuvantIBA 01/2022 - 01/2021
2	SodiumIBA 01/2022 - 10/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2022
2	NitrogenIBA 01/2022 - 09/2003
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2018
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 12/2020
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 09/2003
2	Calcium-Sensing ReceptorsIBA 10/2021 - 01/2020
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 12/2020
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 12/2020
2	Neuroprotective AgentsIBA 12/2020 - 02/2015

Therapy/Procedure

14	Therapeutics 07/2023 - 09/2003
7	Renal Dialysis (Hemodialysis) 01/2023 - 03/2016
7	Liver Transplantation 12/2021 - 12/2007
4	Spinal Injections 01/2022 - 10/2010
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2022
2	Retreatment 10/2023 - 01/2023
2	Induction Chemotherapy 11/2022 - 07/2022
2	Ligation 01/2022 - 01/2022